Land: Canada
Sprog: engelsk
Kilde: Health Canada
BECLOMETHASONE DIPROPIONATE
BAUSCH HEALTH, CANADA INC.
R03BA01
BECLOMETASONE
100MCG
METERED-DOSE AEROSOL
BECLOMETHASONE DIPROPIONATE 100MCG
INHALATION
15G/50G
Prescription
ADRENALS
Active ingredient group (AIG) number: 0106320003; AHFS:
APPROVED
2021-01-01
PRODUCT MONOGRAPH PR QVAR ® Beclomethasone Dipropionate Inhalation Aerosol - Metered Dose Aerosol 50 mcg and 100 mcg CORTICOSTEROID FOR ORAL INHALATION CONTAINS NO CHLOROFLUOROCARBONS (CFCS) (CFC-FREE) BAUSCH HEALTH, CANADA INC. DATE OF REVISION: 2150 St-Elzear Blvd. West December 29, 2020 Laval, Quebec H7L 4A8 Control #: 241786 _Pr_ _QVAR _ _®_ _ Product Monograph Page 2 of 29_ PRODUCT MONOGRAPH PR QVAR ® Beclomethasone Dipropionate Inhalation Aerosol - Metered Dose Aerosol 50 mcg and 100 mcg ACTION AND CLINICAL PHARMACOLOGY Beclomethasone dipropionate is a diester of beclomethasone, a synthetic corticosteroid chemically related to dexamethasone. Beclomethasone differs from dexamethasone in having a chlorine at the 9-alpha carbon in place of a fluorine, and in having a 16 beta-methyl group instead of a 16 alpha-methyl group. Bronchial inflammation is known to be an important component in the pathogenesis of asthma, occurring in both large and small airways. Glucocorticoids have multiple anti-inflammatory effects, inhibiting both inflammatory cells and release of inflammatory mediators. It is presumed that these anti-inflammatory actions play an important role in the efficacy of beclomethasone dipropionate (BDP) in controlling symptoms and improving lung function in asthma. Inhaled BDP probably acts as a topical anti-inflammatory agent at the site of deposition in the bronchial tree. In two studies evaluating the deposition pattern of technetium-99m labeled QVAR (beclomethasone dipropionate), approximately 50-60% of the dose from the actuator (40% of the dose from the valve) of QVAR was deposited in the lungs. The imaging data suggest that QVAR, beclomethasone dipropionate formulated in hydrofluoroalkane-134a (HFA-BDP), deposited widely throughout the central, intermediate, and peripheral airways. In contrast, approximately 4-7% dose from the actuator (5% of the dose from the valve) of beclomethasone dipropionate formulated in chlorofluorocarbons (CFC-BDP) was deposited in the lungs, and deposition was limited Læs hele dokumentet